Structure based on 5i94 |
Ideal structure |
|
| Name: 2-phenyl-n-{5-[4-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide |
| Formula: C25 H25 N7 O3 S2 |
| Weight: 535.641 |
| SMILES: "O=C(Cc1ccccc1)Nc2sc(OC3CCN(CC3)c4sc(NC(=O)Cc5ccccc5)nn4)nn2" |
| Spacial conformation based on PDB
5i94 |
RESIDUE 69V 62
CONECT N12 3 C13 C11 H1
CONECT C13 3 N12 C14 O21
CONECT C15 3 C20 C14 C16
CONECT C17 3 C16 C18 H2
CONECT C20 3 C15 C19 H3
CONECT C26 3 N25 N27 S37
CONECT C28 3 N27 C29 O36
CONECT C01 4 C02 C06 H4 H5
CONECT C02 4 C01 N03 H6 H7
CONECT N03 3 C02 C04 C23
CONECT C04 4 N03 C05 H8 H9
CONECT C05 4 C04 C06 H10 H11
CONECT C06 4 C01 C05 O07 H12
CONECT O07 2 C06 C08
CONECT C08 3 O07 N09 S22
CONECT N09 2 C08 N10
CONECT N10 2 N09 C11
CONECT C11 3 N12 N10 S22
CONECT C14 4 C13 C15 H13 H14
CONECT C16 3 C15 C17 H15
CONECT C18 3 C17 C19 H16
CONECT C19 3 C20 C18 H17
CONECT O21 1 C13
CONECT S22 2 C08 C11
CONECT C23 3 N03 N24 S37
CONECT N24 2 C23 N25
CONECT N25 2 C26 N24
CONECT N27 3 C26 C28 H18
CONECT C29 4 C28 C30 H19 H20
CONECT C30 3 C29 C31 C35
CONECT C31 3 C30 C32 H21
CONECT C32 3 C31 C33 H22
CONECT C33 3 C32 C34 H23
CONECT C34 3 C33 C35 H24
CONECT C35 3 C30 C34 H25
CONECT O36 1 C28
CONECT S37 2 C26 C23
CONECT H1 1 N12
CONECT H2 1 C17
CONECT H3 1 C20
CONECT H4 1 C01
CONECT H5 1 C01
CONECT H6 1 C02
CONECT H7 1 C02
CONECT H8 1 C04
CONECT H9 1 C04
CONECT H10 1 C05
CONECT H11 1 C05
CONECT H12 1 C06
CONECT H13 1 C14
CONECT H14 1 C14
CONECT H15 1 C16
CONECT H16 1 C18
CONECT H17 1 C19
CONECT H18 1 N27
CONECT H19 1 C29
CONECT H20 1 C29
CONECT H21 1 C31
CONECT H22 1 C32
CONECT H23 1 C33
CONECT H24 1 C34
CONECT H25 1 C35
END
HET 69V 62
HETNAM 69V 2-phenyl-N-{5-[4-({5-[(phenylacetyl)amino]-1,3,4-thiadi
HETNAM 2 69V azol-2-yl}oxy)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}ace
HETNAM 3 69V tamide
FORMUL 69V C25 H25 N7 O3 S2
MONOMER page